Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: diablo who wrote (400)	12/21/1998 1:07:00 PM
From: BRAVEHEART	Read Replies (1) \| Respond to of 1494

Hi Diablo, I hope NTII's new media group takes a lesson from CNSI's recent handling of it's recent collaboration for a R&D project. In my opinion NTII's collaboration should be even more significant and much larger. NTII will be collaborating for a product in advanced clinicals. The Street is waiting for Big Pharma to validate Memantine. What better way to address the street than with an early lead through Bloomberg then with a follow up conference call jointly with MERZ. Here is the link to the CNSI story... quote.bloomberg.com PS: I have been accumulating shares from tax loss sellers and will buy more next week... : ) . Patience. BEST WISHES LONE WOLF